Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. Mondeshki, D. Petrova, O. Geordiev, V. Pencheva (Sofia, Bulgaria). Values of diffusing capacity for carbon monoxide (DLco) in patients with obstructive sleep apnoea and chronic obstructive pulmonary disease – (overlap syndrome). Eur Respir J 2007; 30: Suppl. 51, 3047

Member's Comments

No comment yet.

Related content which might interest you: Long term effects of PAP therapy on patients with obstructive sleep apnea (OSA) and chronic obstructive pulmonary disease (COPD) (overlap syndrome) Source: Sleep and Breathing Conference 2021 Year: 2021 Prevalence and characteristics of patients with obstructive sleep apnea (OSA) and chronic obstructive pulmonary disease (COPD): “overlap syndrome (OS)” Source: Virtual Congress 2020 – Prevalence, characteristics and predictors of obstructive sleep apnoea Year: 2020 Nocturnal desaturation without obstructive sleep apnea (OSA) in patients with mild/moderate chronic obstructive pulmonary disease (COPD): a link with systemic inflammation (SI)? Source: Annual Congress 2008 - Comorbidities in COPD Year: 2008 Comparison of plasma NT-proBNP level in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) Source: Annual Congress 2008 - Control of breathing and respiratory disorders during sleep Year: 2008 Metabolic disturbances in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) patients Source: Annual Congress 2010 - Clinical aspects of sleep apnoea Year: 2010 A comparison of pulmonary function, functional exercise capacity and sleep quality in patients with chronic obstructive pulmonary disease and obstructive sleep apnea syndrome Source: Annual Congress 2012 - Assessment of physical activity, exercise, muscle function and clinical characteristics as outcomes in physiotherapy and rehabilitation Year: 2012 CPAP and survival in moderate-to-severe obstructive sleep apnoea syndrome and hypoxaemic COPD Source: Eur Respir J 2010; 35: 132-137 Year: 2010 The effect of physical rehabilitation (PR) on the severity of symptoms of OSAS in patients with chronic obstructive pulmonary disease (COPD) and obstructive sleep apnoea syndrome (OSA) Source: International Congress 2016 – New insights into pulmonary rehabilitation for chronic lung diseases Year: 2016 Analysis of pulmonary function and obstructive sleep apnea in patients with COPD, asthma and idiopathic pulmonary fibrosis. Source: Virtual Congress 2020 – Phenotyping sleep-disordered breathing and its impact on various diseases Year: 2020 CPAP therapy in idiopathic pulmonary fibrosis (IPF) patients with obstructive sleep apnea (OSA) Source: Annual Congress 2012 - Physiology, heart failure and respiration in relation to OSA Year: 2012 High flow-nasal cannula oxygen treatment in patients with concomitant severe chronic obstructive pulmonary diseases and mild-moderate  sleep apnea  (overlap syndrome). Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence Year: 2020 Pulmonary arterial hypertension (PAH) in patients with obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2002; 20: Suppl. 38, 562s Year: 2002 Incidence of cardiovascular complications in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders Year: 2007 Sleep hypoventilation in hypercapnic chronic obstructive pulmonary disease: prevalence and associated factors Source: Eur Respir J 2003; 21: 977-984 Year: 2003 Mean platelet volume and platelet distribution width in patients with obstructive sleep apnea syndrome and chronic obstructive pulmonary disease (overlap syndrome) Source: International Congress 2018 – From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS) Year: 2018 Non invasive ventilation versus continuous positive airway pressure in patients with obstructive sleep apnea syndrome and chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: Suppl. 48, 546s Year: 2004 Reversibility of airflow limitation in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2004; 24: Suppl. 48, 587s Year: 2004 Natural history of idiopathic pulmonary fibrosis (IPF) associated with obstructive sleep apnea (OSA) with or without continuous positive airway pressure (CPAP) Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias Year: 2018 Chronic obstructive pulmonary disease in patients with obstructive sleep apnea Source: Annual Congress 2009 - Control of breathing and respiratory disorders during sleep Year: 2009 Regional ventilatory defects in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2006 - COPD: imaging and computer applications Year: 2006